ID

17350

Beschreibung

ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00140660

Link

https://clinicaltrials.gov/show/NCT00140660

Stichworte

  1. 07.09.16 07.09.16 -
  2. 07.09.16 07.09.16 -
  3. 07.09.16 07.09.16 -
Hochgeladen am

7. September 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diffuse Large Cell Lymphoma NCT00140660

Eligibility Diffuse Large Cell Lymphoma NCT00140660

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient with histologically proven cd20+ diffuse large b-cell lymphoma (who classification).
Beschreibung

Diffuse Large B-Cell Lymphoma Cell positive for CD20 antigen

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0079744
UMLS CUI [1,2]
C0882818
age from 18 to 65 years.
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
patient not previously treated.
Beschreibung

Patient untreated

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0332155
ann arbor stage i or ii.
Beschreibung

Ann Arbor lymphoma staging system

Datentyp

boolean

Alias
UMLS CUI [1]
C0432516
ecog performance status < 2.
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
normal ldh.
Beschreibung

Blood lactate dehydrogenase normal

Datentyp

boolean

Alias
UMLS CUI [1]
C0853788
negative hiv, hbv and hcv serologies 4 weeks (except after vaccination).
Beschreibung

HIV negative | hepatitis b serology Negative | hepatitis C serology test Negative | Vaccination

Datentyp

boolean

Alias
UMLS CUI [1]
C0481430
UMLS CUI [2,1]
C0744837
UMLS CUI [2,2]
C1513916
UMLS CUI [3,1]
C0850489
UMLS CUI [3,2]
C1513916
UMLS CUI [4]
C0042196
having previously signed a written informed consent.
Beschreibung

Informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
any other histological type of lymphoma. vany history of treated or non-treated indolent lymphoma. however, patients not previously diagnosed and having a diffuse large b-cell lymphoma with some small cell infiltration in lymph node may be included.
Beschreibung

Lymphoma Histologic type | indolent lymphoma | Diffuse Large B-Cell Lymphoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0024299
UMLS CUI [1,2]
C0449574
UMLS CUI [2]
C1334170
UMLS CUI [3]
C0079744
central nervous system or meningeal involvement by lymphoma.
Beschreibung

Central Nervous System Involvement with Lymphoma | Meninges Involvement with Lymphoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3714787
UMLS CUI [1,2]
C1314939
UMLS CUI [1,3]
C0024299
UMLS CUI [2,1]
C0025285
UMLS CUI [2,2]
C1314939
UMLS CUI [2,3]
C0024299
contra-indication to any drug contained in the chemotherapy regimens.
Beschreibung

Medical contraindication Pharmaceutical Preparation Related Chemotherapy Regimen

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0439849
UMLS CUI [1,4]
C0392920
poor renal function (creatinin level >150 mmol/l), poor hepatic function (total bilirubin level >30 mmol/l, transaminases >2.5 maximum normal level).
Beschreibung

Renal function Poor | Creatinine measurement | Liver function Poor | Bilirubin, total measurement | Transaminases increased

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0232804
UMLS CUI [1,2]
C0542537
UMLS CUI [2]
C0201975
UMLS CUI [3,1]
C0232741
UMLS CUI [3,2]
C0542537
UMLS CUI [4]
C0201913
UMLS CUI [5]
C0438717
poor bone marrow reserve as defined by neutrophils < 1.5 g/l or platelets < 100 g/l.
Beschreibung

Few mature neutrophils in the bone marrow | Absolute neutrophil count | Platelet Count measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C2748959
UMLS CUI [2]
C0948762
UMLS CUI [3]
C0032181
any history of cancer during the last 5 years with the exception of non-melanoma skin tumors or stage 0 (in situ) cervical carcinoma.
Beschreibung

Malignant Neoplasms | Skin carcinoma | Carcinoma in situ of uterine cervix

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0699893
UMLS CUI [3]
C0851140
any serious active disease (according to the investigator's decision).
Beschreibung

Disease Serious

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205404
treatment with any investigational drug within 30 days before planned first cycle of chemotherapy and during the study.
Beschreibung

Investigational New Drugs | Chemotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
UMLS CUI [2]
C0392920
pregnant or lactating women
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
adult patient under tutelage.
Beschreibung

Adult | guardianship

Datentyp

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0870627

Ähnliche Modelle

Eligibility Diffuse Large Cell Lymphoma NCT00140660

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Diffuse Large B-Cell Lymphoma Cell positive for CD20 antigen
Item
patient with histologically proven cd20+ diffuse large b-cell lymphoma (who classification).
boolean
C0079744 (UMLS CUI [1,1])
C0882818 (UMLS CUI [1,2])
Age
Item
age from 18 to 65 years.
boolean
C0001779 (UMLS CUI [1])
Patient untreated
Item
patient not previously treated.
boolean
C0030705 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
Ann Arbor lymphoma staging system
Item
ann arbor stage i or ii.
boolean
C0432516 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status < 2.
boolean
C1520224 (UMLS CUI [1])
Blood lactate dehydrogenase normal
Item
normal ldh.
boolean
C0853788 (UMLS CUI [1])
HIV negative | hepatitis b serology Negative | hepatitis C serology test Negative | Vaccination
Item
negative hiv, hbv and hcv serologies 4 weeks (except after vaccination).
boolean
C0481430 (UMLS CUI [1])
C0744837 (UMLS CUI [2,1])
C1513916 (UMLS CUI [2,2])
C0850489 (UMLS CUI [3,1])
C1513916 (UMLS CUI [3,2])
C0042196 (UMLS CUI [4])
Informed consent
Item
having previously signed a written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Lymphoma Histologic type | indolent lymphoma | Diffuse Large B-Cell Lymphoma
Item
any other histological type of lymphoma. vany history of treated or non-treated indolent lymphoma. however, patients not previously diagnosed and having a diffuse large b-cell lymphoma with some small cell infiltration in lymph node may be included.
boolean
C0024299 (UMLS CUI [1,1])
C0449574 (UMLS CUI [1,2])
C1334170 (UMLS CUI [2])
C0079744 (UMLS CUI [3])
Central Nervous System Involvement with Lymphoma | Meninges Involvement with Lymphoma
Item
central nervous system or meningeal involvement by lymphoma.
boolean
C3714787 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
C0025285 (UMLS CUI [2,1])
C1314939 (UMLS CUI [2,2])
C0024299 (UMLS CUI [2,3])
Medical contraindication Pharmaceutical Preparation Related Chemotherapy Regimen
Item
contra-indication to any drug contained in the chemotherapy regimens.
boolean
C1301624 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
C0392920 (UMLS CUI [1,4])
Renal function Poor | Creatinine measurement | Liver function Poor | Bilirubin, total measurement | Transaminases increased
Item
poor renal function (creatinin level >150 mmol/l), poor hepatic function (total bilirubin level >30 mmol/l, transaminases >2.5 maximum normal level).
boolean
C0232804 (UMLS CUI [1,1])
C0542537 (UMLS CUI [1,2])
C0201975 (UMLS CUI [2])
C0232741 (UMLS CUI [3,1])
C0542537 (UMLS CUI [3,2])
C0201913 (UMLS CUI [4])
C0438717 (UMLS CUI [5])
Few mature neutrophils in the bone marrow | Absolute neutrophil count | Platelet Count measurement
Item
poor bone marrow reserve as defined by neutrophils < 1.5 g/l or platelets < 100 g/l.
boolean
C2748959 (UMLS CUI [1])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
Malignant Neoplasms | Skin carcinoma | Carcinoma in situ of uterine cervix
Item
any history of cancer during the last 5 years with the exception of non-melanoma skin tumors or stage 0 (in situ) cervical carcinoma.
boolean
C0006826 (UMLS CUI [1])
C0699893 (UMLS CUI [2])
C0851140 (UMLS CUI [3])
Disease Serious
Item
any serious active disease (according to the investigator's decision).
boolean
C0012634 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Investigational New Drugs | Chemotherapy
Item
treatment with any investigational drug within 30 days before planned first cycle of chemotherapy and during the study.
boolean
C0013230 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Adult | guardianship
Item
adult patient under tutelage.
boolean
C0001675 (UMLS CUI [1])
C0870627 (UMLS CUI [2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video